檢索結果 - Yutaka Enomoto

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model

    Neutrophils alleviate fibrosis in the CCl4‐induced mouse chronic liver injury model 由 Eiko Saijou, Yutaka Enomoto, Michitaka Matsuda, Cindy Kok, Shizuo Akira, Minoru Tanaka, Atsushi Miyajima

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Cytokine-enhanced cytolytic activity of exosomes from NK Cells

    Cytokine-enhanced cytolytic activity of exosomes from NK Cells 由 Yutaka Enomoto, Peng Li, Lisa M. Jenkins, Dimitrios G. Anastasakis, Gaelyn C. Lyons, Markus Hafner, Warren J. Leonard

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling

    An Evolutionarily Conserved Mechanism for MicroRNA-223 Expression Revealed by MicroRNA Gene Profiling 由 Taro Fukao, Y. Fukuda, Kotaro Kiga, Jafar Sharif, Kimihiro Hino, Yutaka Enomoto, Aya Kawamura, K Nakamura, Tsutomu Takeuchi, M. Tanabe

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells

    Enhanced Immunogenicity of Heat Shock Protein 70 Peptide Complexes from Dendritic Cell-Tumor Fusion Cells 由 Yutaka Enomoto, Ajit Bharti, Ad Abdul Khaleque, Baizheng Song, Chunlei Liu, Vasso Apostolopoulos, Pei‐Xiang Xing, Stuart K. Calderwood, Jianlin Gong

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome

    Preserved Na/HCO3 cotransporter sensitivity to insulin may promote hypertension in metabolic syndrome 由 Motonobu Nakamura, Osamu Yamazaki, Ayumi Shirai, Shoko Horita, Nobuhiko Satoh, Masashi Suzuki, Yoshifumi Hamasaki, Eisei Noiri, Haruki Kume, Yutaka Enomoto, Yukio Homma, George Seki

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcRγ in Mast Cells

    An Activating and Inhibitory Signal from an Inhibitory Receptor LMIR3/CLM-1: LMIR3 Augments Lipopolysaccharide Response through Association with FcRγ in Mast Cells 由 Kumi Izawa, Jiro Kitaura, Yoshinori Yamanishi, Takayuki Matsuoka, Ayako Kaitani, Masahiro Sugiuchi, Mariko Takahashi, Akie Maehara, Yutaka Enomoto, Toshihiko Oki, Toshiyuki Takai, Toshio Kitamura

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models

    Two types of C/EBPα mutations play distinct but collaborative roles in leukemogenesis: lessons from clinical data and BMT models 由 Naoko Kato, Jiro Kitaura, Noriko Doki, Yukiko Komeno, Naoko Watanabe‐Okochi, Katsuhiro Togami, Fumio Nakahara, Toshihiko Oki, Yutaka Enomoto, Yumi Fukuchi, Hideaki Nakajima, Yuka Harada, Hironori Harada, Toshio Kitamura

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis—Retrospective analysis of 11 case histories

    Idiopathic retroperitoneal fibrosis, inflammatory aortic aneurysm, and inflammatory pericarditis—Retrospective analysis of 11 case histories 由 Aiko Sakamoto, Ryozo Nagai, Kan Saito, Yasushi Imai, Masao Takahashi, Yumiko Hosoya, Norifumi Takeda, Kenji Hirano, Kazuhiko Koike, Yutaka Enomoto, Haruki Kume, Yukio Homma, Daichi Maeda, Hideomi Yamada, Masashi Fukayama, Yasunobu Hirata, Nobukazu Ishizaka

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury

    TIM1 is an endogenous ligand for LMIR5/CD300b: LMIR5 deficiency ameliorates mouse kidney ischemia/reperfusion injury 由 Yoshinori Yamanishi, Jiro Kitaura, Kumi Izawa, Ayako Kaitani, Yukiko Komeno, Masaki Nakamura, Satoshi Yamazaki, Yutaka Enomoto, Toshihiko Oki, Hisaya Akiba, Takaya Abe, Tadasuke Komori, Yoshihiro Morikawa, Hiroshi Kiyonari, Toshiyuki Takai, Ko Okumura, Toshio Kitamura

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression

    CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression 由 Xiaoxiao Liu, Naru Sato, Yuko Shimosato, Teh‐Wei Wang, Tamami Denda, Yu‐Hsuan Chang, Tomohiro Yabushita, Takeshi Fujino, Shuhei Asada, Yosuke Tanaka, Tomofusa Fukuyama, Yutaka Enomoto, Yasunori Ota, Takeharu Sakamoto, Toshio Kitamura, Susumu Goyama

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells

    Prostaglandin E2-EP2/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells 由 Siwakorn Punyawatthananukool, Ryuma Matsuura, Thamrong Wongchang, Nao Katsurada, Tatsuaki Tsuruyama, Masaki Tajima, Yutaka Enomoto, Toshio Kitamura, Masahiro Kawashima, Masakazu Toi, Koji Yamanoi, Junzo Hamanishi, Shigeo Hisamori, Kazutaka Obama, Varodom Charoensawan, Dean Thumkeo, Shuh Narumiya

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder

    A phase I/II study of cancer peptide vaccine S-288310 in patients with advanced urothelial carcinoma of the bladder 由 Wataru Obara, Masatoshi Eto, Hiromitsu Mimata, Kazunori Kohri, Naoki Mitsuhata, Ichiro Miura, Taro Shuin, Takahiro Miki, Takuya Koie, Hiroyuki Fujimoto, Keita Minami, Yutaka Enomoto, Takahito Nasu, Taku Yoshida, Hiroki Fuse, Isao Hara, Keiko Kawaguchi, Akinori Arimura, Tomoaki Fujioka

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment

    Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment 由 Tomohiro Yabushita, Takumi Chinen, Atsuya Nishiyama, Shuhei Asada, Ruka Shimura, Tomoya Isobe, Keita Yamamoto, Naru Sato, Yutaka Enomoto, Yosuke Tanaka, Tomofusa Fukuyama, Hitoshi Satoh, Keiko Kato, Kaori Saitoh, Takamasa Ishikawa, Tomoyoshi Soga, Yasuhito Nannya, Tatsuo Fukagawa, Makoto Nakanishi, Daiju Kitagawa, Toshio Kitamura, Susumu Goyama

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Thiazolidinediones Enhance Sodium-Coupled Bicarbonate Absorption from Renal Proximal Tubules via PPARγ-Dependent Nongenomic Signaling

    Thiazolidinediones Enhance Sodium-Coupled Bicarbonate Absorption from Renal Proximal Tubules via PPARγ-Dependent Nongenomic Signaling 由 Yoko Endo, Masashi Suzuki, Hideomi Yamada, Shoko Horita, Motoei Kunimi, Osamu Yamazaki, Ayumi Shirai, Motonobu Nakamura, Naoyuki Iso-O, Yuehong Li, Masumi Hara, Kazuhisa Tsukamoto, Nobuo Moriyama, Akihiko Kudo, Hayato Kawakami, Toshimasa Yamauchi, Naoto Kubota, Takashi Kadowaki, Haruki Kume, Yutaka Enomoto, Yukio Homma, George Seki, Toshiro Fujita

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations

    Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations 由 Daichi Inoue, Jiro Kitaura, Katsuhiro Togami, Koutarou Nishimura, Yutaka Enomoto, Tomoyuki Uchida, Yuki Kagiyama, Kimihito C. Kawabata, Fumio Nakahara, Kumi Izawa, Toshihiko Oki, Akie Maehara, Masamichi Isobe, Akiho Tsuchiya, Yuka Harada, Hironori Harada, Takahiro Ochiya, Hiroyuki Aburatani, Hiroshi Kimurâ, Felicitas Thol, Michael Heuser, Ross L. Levine, Omar Abdel‐Wahab, Toshio Kitamura

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study

    Enfortumab vedotin versus platinum rechallenge in post‐platinum, post‐pembrolizumab advanced urothelial carcinoma: A multicenter propensity score‐matched study 由 Satoru Taguchi, Taketo Kawai, Y. Ambe, Kenjiro Kishitani, Kazuma Sugimoto, Jimpei Miyakawa, Yu Nakamura, Michio Noda, Tomoyuki Kaneko, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Shigenori Kakutani, Yoshitsune Furuya, Yujiro Sato, Yukari Uemura, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Yutaka Enomoto, Hiroaki Nishimatsu, Tetsuya Fujimura, Hiroshi Fukuhara, Tohru Nakagawa, Satoru Takahashi, Haruki Kume

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: